Inventor
Jong Soo Woo
Inventor
Suwon-si, KR
Overview
Patents· 34 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes35%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C21DModifying the physical structure of ferrous metals6%
C07DHeterocyclic compounds5%
C07CAcyclic or carbocyclic compounds3%
C22CAlloys3%
C23CCoating metallic material3%
Y02ATechnologies for adaptation to climate change3%
A61JContainers specially adapted for medical or pharmaceutical purposes1%
B30BPresses in general1%
PatentTitleYear
10,434,067Composite formulation for oral administration comprising ezetimibe and rosuvastatin201910,422,582Molten iron manufacturing apparatus and molten iron manufacturing method201910,034,862Solid pharmaceutical composition comprising amlodipine and losartan20189,931,406Pharmaceutical composition comprising amide derivative inhibiting the growth of cancer cells and non-metallic salt lubricant20189,867,801'Amorphous solid dispersion comprising taxane, tablet comprising the same, and method for preparing the same'20189,833,413Pharmaceutical combination formulation comprising amlodipine, losartan and rosuvastatin20179,801,876'Complex granule formulation having improved stability comprising levocetirizine and montelukast'20179,731,022'Pharmaceutical composition comprising amide derivative inhibiting the growth of cancer cells and non-metallic salt lubricant'20179,694,007'Oral complex composition comprising pseudoephedrine and levocetirizine'20179,549,936'Method for preparing dry powder for inhalation formulation comprising salmeterol xinafoate, fluticasone propionate and tiotropium bromide'20179,486,528'Stable pharmaceutical formulation for oral administration comprising levocetirizine or a pharmaceutically acceptable salt thereof, and montelukast or a pharmaceutically acceptable salt thereof'20169,283,218'Solid dispersion with improved solubility comprising tetrazole derivative as an active ingredient'20169,283,232'Dry powder for inhalation formulation comprising salmeterol xinafoate, fluticasone propionate and tiotropium bromide, and method for preparing same'20169,220,704'Composite formulation comprising a tablet encapsulated in a hard capsule'20158,673,945'Solid pharmaceutical composition comprising amlodipine and losartan'20148,475,840'Sustained release formulation for oral administration of HMG-CoA reductase inhibitor and method for the preparation thereof'20138,127,516'Method for preparing rapidly disintegrating formulation for oral administration and apparatus for preparing and packing the same'20127,759,368'Sustained release composition for oral administration of niacin'20107,704,526'Sustained release composition for oral administration of drugs'20107,485,326'Oral microemulsion composition comprising biphenyldimethyldicarboxylate and silybin'20097,435,304'Coating composition, and method for manufacturing high silicon electrical steel sheet using thereof'20087,282,102'Method for manufacturing high silicon grain-oriented electrical steel sheet with superior core loss property'20076,936,625'Amlodipine camsylate and method for preparing thereof'20056,706,285'Enteric coated formulation of a benzimidazole derivative and method for preparation thereof'20046,451,128'Method for manufacturing high magnetic flux denshy grain oriented electrical steel sheet based on low temperature slab heating method'20026,428,821'Oral micro-emulsion composition of silybin'20026,107,290'Non-crystalline cefuroxime axetil solid dispersant, process for preparing same and composition for oral administration thereof'20006,039,981'Antifungal oral composition containing itraconazole and process for preparing same'20005,958,876'Cyclosporin-containing pharmaceutical compositions'19995,803,988'Method for manufacturing non-oriented electrical steel sheet showing superior adherence of insulating coated layer'19985,653,821'Method for manufacturing oriented electrical steel sheet by heating slab at low temperature'19975,639,474'Cyclosporin soft capsule composition'19975,603,951'Cyclosporin-containing soft capsule compositions'19975,589,455'Cyclosporin-containing soft capsule compositions'1996Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1996–2019Patents assigned to HANMI PHARM IND CO LTD (20)· patent assignee history
1996–2008Based in Kyungki-do, KR· patent location history
1997Based in Kyong Sang Book-Do, KR· patent location history
1998–2019Based in Pohang-si, KR· patent location history
1999–2019Based in Suwon-si, KR· patent location history
2012–2017Patents assigned to WOO JONG SOO (5)· patent assignee history
2012–2017Patents assigned to KIM KYEONG SOO (3)· patent assignee history
2013–2017Patents assigned to HANMI SCIENCE CO LTD (3)· patent assignee history
2014–2017Patents assigned to PARK JAE HYUN (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| HANMI PHARM IND CO LTD | 20 | 1996–2019 |
| WOO JONG SOOself | 5 | 2012–2017 |
| HANMI SCIENCE CO LTD | 3 | 2013–2017 |
| KIM KYEONG SOO | 3 | 2012–2017 |
| PARK JAE HYUN | 3 | 2014–2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| Suwon-si, KR | 24 | 1999–2019 |
| Kyungki-do, KR | 6 | 1996–2008 |
| Pohang-si, KR | 3 | 1998–2019 |
| Kyong Sang Book-Do, KR | 1 | 1997 |